DÄ internationalArchive13/2007State of Type 2 Diabetes Care in Germany

Editorial

State of Type 2 Diabetes Care in Germany

One Study, Two Interpretations

Dtsch Arztebl 2007; 104(13): A-859

Abholz, H

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Sawicki PT, Vester EG: Kardiale Komplikationen bei Diabetes mellitus. In: Berger M (ed.): Diabetes mellitus, 2. Auflage München: Urban & Fischer 2000.
2. Hovens NM, Tamsma JT, Beishuizen ED, Huisman HV: Pharmacological strategies to reduce cardiovascular risk in typ 2 diabetes mellitus: an update. Drugs 2005; 65: 433–45.
3. The Royal College of General Practitioners/Effective Clinical Practice Unit, Sheffield/NICE: Clinical guidelines for typ 2 diabetes – Blood pressure management/lipid management. www.shef.ac.uk/guidelines
4. De Baker G et al.: European guidelines on cardiovascular disease prevention in general practice. Europ Heart J 2003; 24: 1601–10.
5. Borgers D: Kardiovaskuläre Primär-Prävention: wie behandelt man multifaktorielles Risiko? Zeitschr Allg Med 2004; 80: 463–9.
6. Jackson R, Carlene M, Lawes M et al.: Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005, 365: 434–41. MEDLINE
7. New Zealand Guidelines: Evidence based best practice guidelines: Assessment and Management of cardiovascular risk. 2003. http://www.nzgg.org.nz/guidelines/0035/CVD_Risk_Full.pdf
8. Snow V, Weiss KB, Matur-Pilson C et al.: The evidence base for tight blood pressure control in the management of typ 2 diabetes mellitus. Ann Intern Med 2003, 138: 587–92. MEDLINE
9. Pogach L, Engelgau M, Aron D: Measuring progress towards achieving HbA1c goals in diabtes care. JAMA 2007; 297: 520–3. MEDLINE
10. NHG-Standaard: Cardiovasculaire risicomangement; vers. 2007, N 84. http://nhg.artsennet.nl/content/resources//AMGATE_6059_104_TICH_R1195991373945248//

Info

Specialities